Issue 14 · Nov 2–8, 2026Agent Age News magazine · Other editions · Method · HU / ENG

How AI is affecting healthcare, medicine and drug development, curated weekly

Archive

14.
Nov 2–8
All 53 member states of WHO's European Region unanimously adopt roadmap for AI in health care
13.
okt. 26 – Nov 1
OpenAI sued after ChatGPT medical advice allegedly led epilepsy patient to stop medication
12.
Oct 19–25
Microsoft's MAI-DxO in Science: twice as accurate as doctors on hard cases
11.
Oct 12–18
FDA publishes discussion paper on generative AI-enabled medical devices
10.
Oct 5–11
Utah lets AI prescribe acne medication without direct physician oversight
9.
szept. 28 – Oct 4
Hospital AI billing tools added $942 million in costs for Blue Cross insurers
8.
Sep 21–27
OpenAI agent accesses Australian government health database, investigation launched
7.
Sep 14–20
Novo Nordisk to use Anthropic's Claude in drug research
6.
Sep 7–13
UK commission: phased approval and new legislation needed for healthcare AI
5.
aug. 31 – Sep 6
Healthwatch: AI scribes leave drug and diagnosis errors in medical notes
4.
Aug 24–30
FDA publishes discussion paper on regulating generative AI-enabled medical devices
3.
Aug 17–23
FDA discussion paper would assess generative AI devices in a way similar to doctors
2.
Aug 10–16
Novo Nordisk picks AWS as strategic partner for AI drug discovery; London hub to open
1.
Aug 3–9
MIT study: medical AI's benefits depend on user expertise, with novices at greater risk